Search results
Results from the Tech24 Deals Content Network
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. The primary goal of the Cancer Center is to ...
Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia, which led to the development of other chemotherapeutic agents against other malignancies. Farber was also active in cancer research ...
James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital. [1] [2] He is considered an expert in medical oncology and is widely recognized for his research in ...
1. Launch AOL Desktop Gold. 2. On the sign on screen, click the small arrow pointing down. 3. Click Add Username. 4. Type in another username and click Continue.Enter your password in the window that appears.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Edward J. Benz Jr. is the former president of Dana–Farber Cancer Institute in Boston, Massachusetts., [1] and the Richard and Susan Smith Professor of Medicine [2] as well as a professor of genetics at Harvard Medical School. [3] He was named to the presidency of Dana-Farber in 2000, succeeding David G. Nathan. [4]
x. AOL works best with the latest versions of the browsers. You're using an outdated or unsupported browser and some AOL features may not work properly.
Toni K. Choueiri is a Lebanese American medical oncologist and researcher. He is the Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School and Director of the Lank Center for Genitourinary Oncology at the Dana–Farber Cancer Institute. His work has led to the establishment of several novel drugs (cabozantinib, avelumab ...